Metyrapone Versus Osilodrostat in Patients With Metabolic Autonomous Cortisol Secretion (MACS)

NCT07268222 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Mild Autonomous Cortisol Secretion (MACS)

Interventions

DRUG: Metyrapone 250 mg Oral Tablets
DRUG: Osilodrostat 1 MG
PROCEDURE: adrenalectomy
OTHER: Watch and wait

Sponsor

Laikο General Hospital, Athens